Standout Papers
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America (2009)
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (2004)
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (2004)
- Macrophage migration inhibitory factor: a regulator of innate immunity (2003)
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer (2002)
- MIF as a glucocorticoid-induced modulator of cytokine production (1995)
- MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia (1993)
- The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. (1994)
- Sepsis: a roadmap for future research (2015)
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes (2007)
- Protection from septic shock by neutralization of macrophage migration inhibitory factor (2000)
- The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit (2005)
- An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. (1996)
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock (1990)
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (2016)
- Changes in the epidemiological landscape of invasive candidiasis (2017)
- The pathophysiology of sepsis and precision-medicine-based immunotherapy (2024)
Immediate Impact
4 by Nobel laureates 19 from Science/Nature 146 standout
Citing Papers
Sepsis and Septic Shock
2024 Standout
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
2021 Standout
Works of Thierry Calandra being referenced
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
2016 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thierry Calandra | 12609 | 13272 | 7998 | 253 | 33.1k | |
| Richard S. Hotchkiss | 14457 | 21689 | 3683 | 202 | 42.0k | |
| Tom van der Poll | 20235 | 29676 | 7570 | 868 | 69.0k | |
| Richard L. Simmons | 5859 | 6170 | 3418 | 582 | 31.8k | |
| Steven M. Opal | 9759 | 23924 | 4618 | 265 | 42.8k | |
| Djillali Annane | 4419 | 19958 | 2788 | 394 | 40.7k | |
| Lyle L. Moldawer | 10763 | 8678 | 1414 | 520 | 31.5k | |
| J.W.M. van der Meer | 16583 | 8881 | 8212 | 565 | 37.8k | |
| Edward Abraham | 12422 | 12139 | 1216 | 333 | 37.4k | |
| Joseph E. Parrillo | 3432 | 11852 | 1611 | 327 | 25.6k | |
| Mitchell P. Fink | 5758 | 9302 | 757 | 271 | 26.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...